期刊
CLINICAL MICROBIOLOGY AND INFECTION
卷 15, 期 6, 页码 592-595出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1469-0691.2009.02794.x
关键词
Antibodies; Candida germ tube; critically ill patients; ICU; invasive candidiasis; mortality; pre-emptive antifungal therapy
资金
- Pfizer
The present study, comprising a prospective multicentre study including 53 non-neutropenic patients from intensive care units (ICU) in six Spanish tertiary-care hospitals, was carried out to determine the clinical significance and influence on mortality of Candida albicans germ tube-specific antibodies (CAGTA). There were 22 patients (41.5%) for whom the CAGTA results were positive, although none of had a blood culture positive for Candida. The intra-ICU mortality rate was significantly lower (p = 0.004) in CAGTA-positive patients (61.2% vs. 22.7%). Multivariate analysis confirmed that a positive CAGTA result was the only protective factor to be independently associated with ICU mortality (beta coefficient = -0.3856; 95% confidence interval = -0.648 to -0.123).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据